Interview with Piero Di Lorenzo «The Oxford vaccine has an efficacy of 90%»
Source: Il Messaggero
Interview with Matteo Liguori. Research needs time
Source: Fortune Italia
The experts warn: “The virus also attacks the brain”
Source: la Repubblica
Covid, a young international team: that’s how Pomezia works on the vaccine
In an 80,000 m2 site 20 miles from Rome, young researchers from around the world work day and night making history. They have played a key role in the development of the Covid-19 vaccine, after the Jenner Institute (expert in…
Interview with Piero Di Lorenzo. The Italian company. Enthusiasm in Rome: «But now we have to be cautious»
Source: Corriere della Sera
Interview with Matteo Liguori: «Everything will depend on tests on subjects at risk»
Source: la Repubblica
Italy in pole position in the vaccine race
Source: il Tempo
London reserves 30 million doses of the vaccine born between Oxford and Pomezia (Rome)
Source: la Repubblica
Interview with Pietro Di Lorenzo “Vaccine ready in September”
Source: il Giornale
Gates funds the project of Oxford (and of Pomezia, Rome)
Source: Il Messaggero
Vaccines: which one will be the good one?
Source: Il Messaggero
The Italian vaccine in clinical trial
Source: Il Sole 24 Ore
